Latest in Therapy

Sort by

2 items

Blind children given sight after experimental gene therapy

Four toddlers born with a rare eye condition have seen "life-changing improvements", say UK doctors.
BBC News - 1d
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
CNBC - 23h